Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
184 hedge funds and large institutions have $1.88B invested in Arena Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 53 reducing their positions, and 26 closing their positions.
80% more call options, than puts
Call options by funds: $21.7M | Put options by funds: $12.1M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
27% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 26
23% more capital invested
Capital invested by funds: $1.53B → $1.88B (+$352M)
13% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 53
4% more funds holding
Funds holding: 177 → 184 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$43.1M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$31M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$30.5M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11M |
| 5 |
SPC
Slate Path Capital
New York
|
+$9.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$19.5M |
| 2 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$12.3M |
| 3 |
TA
Teachers Advisors
New York
|
-$11.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.7M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$6.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CSS
201
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$157K | -4,022 | Closed |
|
|
FQ
202
First Quadrant
Glendale,
California
| – | -$83K | -2,141 | Closed |
|
|
AIM
203
Assured Investment Management
New York
| – | -$57K | -1,463 | Closed |
|
204
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$27K | -703 | Closed |
|
|
PRC
205
Pearl River Capital
Niles,
Michigan
| – | -$17K | -432 | Closed |
|
|
DWM
206
Doyle Wealth Management
St. Petersburg,
Florida
| – | -$8K | -200 | Closed |
|
207
Parallax Volatility Advisers
San Francisco,
California
| – | -$5.96K | -130 | Closed |
|
|
ER
208
Enlightenment Research
Miami,
Florida
| – | -$4K | -100 | Closed |
|
ARNA Hedge Fund Activity: Q1 2019 in Review
184 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2019, worth a combined $1.88B — up 23% from $1.53B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ARNA positions and 26 closed out — a net gain of 7 holders — while 60 added to existing stakes and 53 trimmed.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $43.1M. The largest seller was Camber Capital Management, exiting entirely with an estimated $19.5M sold.
- 184 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2019, up from 177 in Q4 2018.
- Funds reported $1.88B of Arena Pharmaceuticals Inc stock for Q1 2019, up 23% quarter-over-quarter.
- 33 funds opened new Arena Pharmaceuticals Inc positions in Q1 2019 and 26 closed out, a net change of +7 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q1 2019 was Eagle Asset Management, an estimated $43.1M added.
- The largest Arena Pharmaceuticals Inc seller in Q1 2019 was Camber Capital Management, an estimated $19.5M sold.
Based on aggregated 13F filings for Q1 2019.